Trial
NCT05401058
Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery
UnknownTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
RenJi Hospital
Collaborators
—
Condition
Digestive System Disease
Intervention
Droperidol Injection
Why stopped
The trial was terminated on the independent DSMB's recommendation after an interim analysis showed no evidence of benefit and a numerically higher incidence of postoperative delirium in the droperidol group, raising a potential safety concern.
Provenance
Dataset: 2026-08-14 • Source: ClinicalTrials.gov API v2 • Last update: 2026-08-12